Lauren Biscaldi, MS, Managing Editor

There are only a few long-term treatments currently available for adolescents with moderate to severe AD.

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.

Only the 60 mg dose of atogepant is approved for chronic migraine prevention.

Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.

HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.

Four independent pharmacists shared their journeys to become pharmacy owners.

Project NextGen will focus on the development of vaccines and long-lasting monoclonal antibody COVID-19 treatments.

The theme of the upcoming Summit is the Expansion of Services Within Independent Pharmacy.

Pharmacists can provide support and guidance to patients during their month of fasting.

Naloxone hydrochloride nasal spray (Narcan) 4 mg is expected to be available over the counter in late summer 2023.

Are pharmacists obligated to correct medical misinformation they encounter online?

From variants to vaccines, much has changed in the COVID-19 landscape.

Pharmacogenetic testing and therapeutic drug monitoring are feasible in the inpatient psychiatric treatment setting.

Emergency medical services runs increased in all 4 US Census regions.

It is crucial to have a measure to mitigate the possibility of seizures, according to researchers.

Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.

The 2023 AAP Annual Conference will take place in New Orleans from April 20 to 22.

As sessions end for the day, head out to explore the city of Phoenix.

APhA 2023 will take place March 24 to March 27 in Phoenix, Arizona

The CGM provides accurate readings over 10.5 days of continuous wear.

The expansion was based on 4-year data from the monarchE study.

Results of an analysis of the VOYAGER PAD clinical trial were presented at ACC.23.

The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.

The Total Pharmacy® Solutions Summit will take place on April 8, 2023.

The PDFUA date for the drug is October 13, 2023.

The letter outlined 7 steps that the Biden administration can take without the need for additional legislation.

The groups released 8 recommendations to support action across the health care community.